Growth Metrics

Sarepta Therapeutics (SRPT) Shareholder's Equity (QoQ) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Sarepta Therapeutics 1.86 Bn 1.17 Bn 291.52 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 31.95%
Dec 31, 2025 -13.60%
Sep 30, 2025 -2.75%
Jun 30, 2025 18.79%
Mar 31, 2025 -25.20%
Dec 31, 2024 25.11%
Sep 30, 2024 13.37%
Jun 30, 2024 12.06%
Mar 31, 2024 11.85%
Dec 31, 2023 12.43%
Sep 30, 2023 3.09%
Jun 30, 2023 4.02%
Mar 31, 2023 85.15%
Dec 31, 2022 -10.65%
Sep 30, 2022 -40.69%
Jun 30, 2022 -15.22%
Mar 31, 2022 -7.66%
Dec 31, 2021 97.65%
Sep 30, 2021 -3.21%
Jun 30, 2021 -9.40%
Mar 31, 2021 -29.71%
Dec 31, 2020 -14.61%
Sep 30, 2020 -14.46%
Jun 30, 2020 -8.91%
Mar 31, 2020 39.92%
Dec 31, 2019 -17.79%
Sep 30, 2019 -9.46%
Jun 30, 2019 -18.49%
Mar 31, 2019 30.64%
Dec 31, 2018 61.33%
Sep 30, 2018 -8.47%
Jun 30, 2018 -10.00%
Mar 31, 2018 -1.58%
Dec 31, 2017 13.21%
Sep 30, 2017 84.54%
Jun 30, 2017 -11.97%
Mar 31, 2017 27.46%
Dec 31, 2016 -17.60%
Sep 30, 2016 236.43%
Jun 30, 2016 -12.59%
Mar 31, 2016 -27.00%
Dec 31, 2015 54.46%
Sep 30, 2015 -25.48%
Jun 30, 2015 -17.62%
Mar 31, 2015 -18.94%
Dec 31, 2014 -13.47%
Sep 30, 2014 -4.57%
Jun 30, 2014 30.99%
Mar 31, 2014 -7.37%
Dec 31, 2013 0.08%
Sep 30, 2013 178.07%
Jun 30, 2013 1.76%
Mar 31, 2013 -29.43%
Mar 31, 2012 -54.79%
Dec 31, 2011 -2.31%
Sep 30, 2011 -9.66%